Skip to content
Announcement:

The results of a recent collaboration between Sanofi, GSK, Lilly, Vesalius Therapeutics, Leiden University, Heidelberg University, ElmorePathology and Newcells aimed at enhancing safety assessments has just been published. Find out how rat kidney gene co-expression networks has enabled biomarker identification and human translation for renal safety assessments.

Retinal Organoids as an Emerging Tool for Drug Discovery

In this webinar, Dr Valeria Chichagova (Chief Technology Officer at Newcells) presents on “Retinal Organoids as an Emerging Tool for Drug Discovery”.

Date: Friday 17th September 2021

Published

11th November, 2021

Share on social media:

Don't miss out on our latest innovations: follow us on Linkedin

View Today

Please enter the required details to view the webinar. You are not automatically signing up for receiving marketing emails.


Get our latest updates straight to your inbox

Book a Call